HUITING ZHANG: Open Payments
NPI 1679082416 · NEW YORK, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$847 in 22 payments from 9 companies in 2025. Trend: 2023 $302 · 2024 $1,121 · 2025 $847
Food & beverage: $767Education: $80
| Company | Payments | Amount |
|---|---|---|
| Merck Sharp & Dohme LLC | 7 | $257 |
| Eisai Inc. | 4 | $221 |
| SEAGEN INC. | 1 | $80 |
| Janssen Biotech, Inc. | 2 | $77 |
| PFIZER INC. | 3 | $70 |
| Gilead Sciences, Inc. | 2 | $60 |
| TOLMAR, INC. | 1 | $28 |
| pharmaand GmbH | 1 | $28 |
| AstraZeneca Pharmaceuticals LP | 1 | $27 |
Products named: KEYTRUDA, Lenvima, ERLEADA, RUBRACA, LYNPARZA, PADCEV, XTANDI, INLYTA.
Industry payments across NY — which companies pay providers there.
